Showing results (301-310 of 346) with videos related to
Sort By:
Pageof 35
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 5, 2019
The Infectious Diseases Society of America's 10 × '20 Initiative (10 New Systemic Antibacterial Agents US Food and Drug Administration Approved by 2020): Is 20 × '20 a Possibility?George H Talbot, Amanda Jezek, Barbara E Murray, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 26, 2025
Pivmecillinam for Treatment of Uncomplicated Urinary Tract Infection: New Efficacy AnalysisThomas P Lodise, Anita F Das, Niels Frimodt-Møller, et al.Clinical Therapeutics|July 31, 2017
A Phase II Randomized, Double-blind, Multicenter Study to Evaluate Efficacy and Safety of Intravenous Iclaprim Versus Vancomycin for the Treatment of Nosocomial Pneumonia Suspected or Confirmed to be Due to Gram-positive PathogensDavid B Huang, Thomas M File, Antoni Torres, et al.Critical Care (London, England)|June 20, 2006
Protein C concentrations in severe sepsis: an early directional change in plasma levels predicts outcomeAndrew F Shorr, Gordon R Bernard, Jean-Francois Dhainaut, et al.Critical Care (London, England)|July 24, 2014
Modeling the economic impact of linezolid versus vancomycin in confirmed nosocomial pneumonia caused by methicillin-resistant Staphylococcus aureusDipen A Patel, Andrew F Shorr, Jean Chastre, et al.The Pediatric Infectious Disease Journal|June 14, 2019
Safety and Efficacy of Tigecycline to Treat Multidrug-resistant Infections in Pediatrics: An Evidence SynthesisMike Sharland, Keith A Rodvold, Hal R Tucker, et al.Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|May 26, 2004
Single-dose pharmacokinetic study of lycopene delivered in a well-defined food-based lycopene delivery system (tomato paste-oil mixture) in healthy adult male subjectsDavid M Gustin, Keith A Rodvold, Jeffery A Sosman, et al.The Journal of Antimicrobial Chemotherapy|March 28, 2025
Impact of obesity on clinical outcomes in patients treated with ceftobiprole: results from Phase 3 clinical trialsThomas L Holland, Andrew F Shorr, J Scott Overcash, et al.BMC Infectious Diseases|July 13, 2012
Development and validation of a bedside risk score for MRSA among patients hospitalized with complicated skin and skin structure infectionsMarya D Zilberberg, Paresh Chaudhari, Brian H Nathanson, et al.Antimicrobial Agents and Chemotherapy|November 23, 2011
Influence of body weight, ethnicity, oral contraceptives, and pregnancy on the pharmacokinetics of azithromycin in women of childbearing ageJames H Fischer, Gloria E Sarto, Mitra Habibi, et al.Pageof 35